Author Correction Published: New Insights into Shared Genetic Pathways of Neurodegenerative Diseases
St. Louis, MO – A correction has been published regarding the research article “Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases,” detailing affiliations for all contributing authors. The study, led by researchers at Washington University School of Medicine, identifies overlapping genetic factors influencing frontotemporal dementia (FTD), Alzheimer’s disease (AD), and Parkinson’s disease (PD), potentially opening new avenues for therapeutic development.
The research team, comprised of scientists from institutions across the United States, United Kingdom, Sweden, and the Netherlands, meticulously analyzed genomic data too pinpoint shared and distinct genetic underpinnings of these debilitating neurodegenerative conditions.
Key affiliations of the research team include: the Department of Psychiatry and NeuroGenomics and informatics center at Washington University School of Medicine (Muhammad Ali, Yike Chen, Ying Xu, Katherine Gong, Menghan Liu, Jigyasha Timsina, Daniel Western, Chengran Yang, Gyujin Heo & Carlos Cruchaga); the Department of Psychiatry, University of Oxford (Buddhiprabha Erabadda & Laura Winchester); Clinical Memory Research Unit and Department of Clinical Sciences Malmö, Lund university, Sweden (Alexa Pichet Binette & Oskar Hansson, with Jacob W. Vogel also affiliated with SciLifeLab, Lund University); Alzheimer Center Amsterdam and Amsterdam Neuroscience (Betty M. Tijms); Gates Ventures (Varsha Krishna & Farhad Imam); and Eli Lilly, Stockholm (Oskar Hansson). Carlos Cruchaga also holds affiliations with the Department of Neurology, Hope Center for Neurological Disorders, and Department of Genetics at Washington University School of Medicine.The full list of members and their affiliations is available in the Supplementary Details accompanying the published correction. This clarification ensures accurate attribution for the collaborative effort driving advancements in understanding and combating these complex diseases.
